Viewing Study NCT06132503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2026-02-22 @ 6:47 PM
Study NCT ID: NCT06132503
Status: RECRUITING
Last Update Posted: 2025-03-17
First Post: 2023-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Sponsor: Lantern Pharma Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory Lymphomas View
None Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LP-284 View
None Phase 1a/1b View
None Lantern Pharma View
None Cancer View
None lymphoma View
None DLBCL View
None MCL View
None Sarcoma View